Bo Zhang

TL;DR: This is the first large-scale proteogenomics analysis across traditional histological boundaries to uncover foundational pediatric brain tumor biology and inform rational treatment selection.

TL;DR: This clinical trial evaluated whether whole exome sequencing and RNA sequencing of paired normal and tumor tissues could be incorporated into a personalized treatment plan for newly diagnosed patients with diffuse intrinsic pontine glioma (DIPG) and results did not significantly deviate from WES‐based therapy recommendations.

TL;DR: Overall, DNT-MNGT spectrum tumors exhibit diverse genomic alterations, with more than half (19/33) leading to MAPK/PI3K pathway alterations.

TL;DR: In the published version of this article, the degree of author Bo Zhang was incorrectly listed as PhD, while the correct degree is BS.